Federal Register / Vol. 76, No. 33 / Thursday, February 17, 2011 / Notices 9353 

inadequate time for all comments to be 

heard on March 14, 2011. 

Additional Information: Contact 

CAPT Juliana Sadovich, RN, PhD, 

Director, Office of Human Services 

Emergency Preparedness and Response, 

e-mail Juliana.Sadovich@acf.hhs.gov or 

call (202) 401–9306. 

SUPPLEMENTARY INFORMATION: The 

National Commission on Children and 

Disasters is an independent Commission 

directed to conduct a comprehensive 

study to examine and assess the needs 

of children as they relate to preparation 

for, response to, and recovery from all 

hazards, building upon the evaluations 

of other entities and avoiding 

unnecessary duplication by reviewing 

the findings, conclusions, and 

recommendations of these entities. The 

Commission submitted reports to the 

President and the Congress on the 

Commission’s independent and specific 

findings, conclusions, and 

recommendations to address the needs 

of children as they relate to preparation 

for, response to, and recovery from all 

hazards, including major disasters and 

emergencies. 

Dated: February 10, 2011. 

David A. Hansell, 

Acting Assistant Secretary for Children and 

Families. 

[FR Doc. 2011–3603 Filed 2–16–11; 8:45 am] 

BILLING CODE 4184–06–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Statement of Delegation of Authority 

Notice is hereby given that I have 

delegated to the Administrator, Health 

Resources and Services Administration 

(HRSA), the authorities vested in the 

Secretary under Section 4101(a) of the 

Patient Protection and Affordable Care 

Act (Pub. L. 111–148) (42 U.S.C. 280h– 

4), as amended hereafter, and Section 

4101(b) of the Patient Protection and 

Affordable Care Act (Pub. L. 111–148) 

amending Section 399Z–1 of the Public 

Health Service Act (42 U.S.C. 280h–5), 

as amended hereafter. These authorities 

may be redelegated. 

This delegation excludes the authority 

to issue regulations, to establish 

advisory committees and councils, and 

appoint their members, and to submit 

reports to Congress, and shall be 

exercised in accordance with the 

Department’s applicable policies, 

procedures, and guidelines. 

I herby affirm and ratify any actions 

taken by the Administrator, HRSA, or 

other HRSA officials, which involved 

the exercise of these authorities prior to 

the effective date of this delegation. 

This delegation is effective upon date 

of signature. 

Dated: February 10, 2011. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. 2011–3587 Filed 2–16–11; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Statement of Delegation of Authority 

Notice is hereby given that I have 

delegated to the Administrator, Health 

Resources and Services Administration 

(HRSA), the authority vested in the 

Secretary under Section 10502 of the 

Patient Protection and Affordable Care 

Act, as amended hereafter, as it pertains 

to the functions assigned to HRSA. This 

authority may be redelegated. 

This delegation excludes the authority 

to issue regulations, to establish 

advisory committees and councils, and 

appoint their members, and to submit 

reports to Congress, and shall be 

exercised in accordance with the 

Department’s applicable policies, 

procedures, and guidelines. 

I hereby affirm and ratify any actions 

taken by the Administrator, HRSA, or 

other HRSA officials, which involved 

the exercise of this authority prior to the 

effective date of this delegation. 

This delegation is effective upon date 

of signature. 

Dated: February 10, 2011. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. 2011–3586 Filed 2–16–11; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Quantitative Imaging for Evaluation of 

Responses to Cancer Therapies. 

Date: March 2, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Gerald G. Lovinger, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8101, 

Bethesda, MD 20892–8329, 301/496–7987, 

lovingeg@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; The Role of 

Microbial Metabolites in Cancer Prevention 

and Etiology. 

Date: March 7, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Gerald G. Lovinger, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8101, 

Bethesda, MD 20892–8329, 301/496–7987, 

lovingeg@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Quantitative Imaging for Tumor 

Microenvironment. 

Date: March 9, 2011. 

Time: 8 a.m. to 10 a.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Zhiqiang Zou, MD, PhD, 

Scientific Review Officer, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8055A, Bethesda, MD 

20852, zouzhiq@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Development of Image Processing and 

Analysis Software for Oncology. 

Date: March 9, 2011. 

Time: 10 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Zhiqiang Zou, MD, PhD, 

Scientific Review Officer, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8055A, Bethesda, MD 

20852, zouzhiq@mail.nih.gov. 


jlentini on DSKJ8SOYB1PROD with NOTICES